Cerner Co. (NASDAQ:CERN) EVP John Peterzalek sold 42,767 shares of Cerner stock in a transaction on Friday, September 13th. The stock was sold at an average price of $68.33, for a total transaction of $2,922,269.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
John Peterzalek also recently made the following trade(s):
- On Thursday, August 22nd, John Peterzalek sold 27,484 shares of Cerner stock. The stock was sold at an average price of $72.11, for a total transaction of $1,981,871.24.
Cerner stock traded down $0.09 during mid-day trading on Monday, reaching $67.76. The stock had a trading volume of 1,003,627 shares, compared to its average volume of 2,390,813. The company has a market capitalization of $21.65 billion, a price-to-earnings ratio of 30.66, a PEG ratio of 1.92 and a beta of 0.92. The company has a 50-day moving average price of $70.02 and a two-hundred day moving average price of $67.07. Cerner Co. has a one year low of $48.78 and a one year high of $76.47. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 9th. Investors of record on Wednesday, September 25th will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date is Tuesday, September 24th. Cerner’s payout ratio is 32.58%.
Several brokerages recently commented on CERN. Piper Jaffray Companies lifted their target price on shares of Cerner from $74.00 to $80.00 and gave the stock an “overweight” rating in a research note on Thursday, July 25th. Morgan Stanley lifted their price target on shares of Cerner from $49.00 to $62.00 and gave the company an “underweight” rating in a report on Friday, August 23rd. Citigroup lifted their price target on shares of Cerner from $77.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, July 25th. BidaskClub cut shares of Cerner from a “sell” rating to a “strong sell” rating in a report on Friday, September 6th. Finally, Canaccord Genuity lifted their price target on shares of Cerner from $77.00 to $80.00 and gave the company a “buy” rating in a report on Thursday, July 25th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the stock. Cerner has a consensus rating of “Buy” and a consensus target price of $74.73.
A number of institutional investors have recently made changes to their positions in the stock. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Cerner by 33.7% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 669,980 shares of the company’s stock worth $49,110,000 after purchasing an additional 168,888 shares in the last quarter. Toronto Dominion Bank boosted its stake in Cerner by 3.8% in the 2nd quarter. Toronto Dominion Bank now owns 231,104 shares of the company’s stock worth $16,935,000 after purchasing an additional 8,379 shares in the last quarter. Atria Investments LLC bought a new position in Cerner in the 2nd quarter worth about $270,000. Arjuna Capital boosted its stake in Cerner by 4.5% in the 2nd quarter. Arjuna Capital now owns 9,188 shares of the company’s stock worth $673,000 after purchasing an additional 398 shares in the last quarter. Finally, Barings LLC bought a new position in Cerner in the 2nd quarter worth about $2,001,000. Institutional investors own 82.66% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: The Discount Rate – What You Need to Know
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.